Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Chan, Andrew T	Massachusetts General Hospital United States	Precision Prevention Research Program	5R35CA253185-06	Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs	5U2CCA271895-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chapkin, Robert Stephen	Texas A&M Agrilife Research United States	Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling	5R01CA244359-05	Amit Kumar, Ph.D.
Chen, Grace Y.	University Of Michigan At Ann Arbor United States	Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention	5R21CA273646-02
Chen, Ru	Baylor College Of Medicine United States	BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION	4UH3CA292130-02	Claire Zhu, Ph.D.
Cheville, Andrea Lynne	Mayo Clinic Rochester United States	Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial	5R33CA278594-04	Brennan Streck, Ph.D., RN, M.P.H.
Chiang, Cheng-Ming	Ut Southwestern Medical Center United States	Small Compound Inhibitors Targeting HPV Genome Replication	1R01CA288743-01A1
Chibwesha, Carla J	Univ Of North Carolina Chapel Hill United States	Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV	5R01CA250850-05	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Chinnaiyan, Arul M	University Of Michigan At Ann Arbor United States	Michigan-VUMC Biomarker Characterization Center	5U2CCA271854-04	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chirenje, Zvavahera Mike	University Of California, San Francisco United States	Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)	3UG1CA284918-03S1	Maria Silvina Frech, Ph.D., M.S.
Chong, Catherine Daniela	Mayo Clinic Arizona United States	Biomarker Signature to Predict the Persistence of Post-Traumatic Headache	5R33NS113315-03	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Chung, Michael Hoonbae	Emory University United States	HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya)	3UG1CA275400-04S1	Maria Silvina Frech, Ph.D., M.S.
Chung, Ki Young	Prisma Health - Upstate United States	NCORP of the Carolinas (Greenville Health System NCORP)	3UG1CA189972-11S1	Vanessa A. White, M.P.H.
Chung, Raymond T	Massachusetts General Hospital United States	Trial of Statins for Chemoprevention in Hepatocellular Carcinoma	4R01CA255621-05	Asad Umar, D.V.M., Ph.D.
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis	5R01CA262551-04	Nancy J. Emenaker, Ph.D., RDN, LD, FAND

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants